| Stage | BX | % of rev | MORN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.0B | 100.00% | $672M | 100.00% | BX ×7.50 |
| Gross profit | $5.0B | 100.00% | $431M | 64.19% | BX +35.8pp |
| Operating income | $2.7B | 52.90% | $167M | 24.91% | BX +28.0pp |
| Pre-tax income | $2.8B | 55.68% | $152M | 22.68% | BX +33.0pp |
| Net income | $2.4B | 46.71% | $116M | 17.18% | BX +29.5pp |
| Stage | BX | MORN | Gap · A − B |
|---|---|---|---|
| Revenue | $5.0B100.00% | $672M100.00% | BX ×7.50 |
| Gross profit | 100.00%$5.0B | 64.19%$431M | BX +35.8pp |
| Operating income | 52.90%$2.7B | 24.91%$167M | BX +28.0pp |
| Pre-tax income | 55.68%$2.8B | 22.68%$152M | BX +33.0pp |
| Net income |
| 46.71%$2.4B |
| 17.18%$116M |
| BX +29.5pp |
No shared counterparties.